Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Dexcom (DXCM)

DexCom promotes COO Jacob Leach to president, keeps Kevin Sayer as CEO

Neutral Impact 3 of 5 leadership Written later

DexCom promoted Jacob S. Leach, its chief operating officer, to president and chief operating officer effective immediately, as of May 9, 2025. Chief Executive Officer Kevin Sayer remains CEO and Chairman, and Leach now reports to him. The filing does not describe a change to financial results or guidance.

Key points

  • Jacob S. Leach promoted to President and COO effective May 9, 2025; he reports to CEO Kevin Sayer
  • Annual base salary raised to $800,000, with a target annual cash bonus equal to 100% of base salary
  • In the president role, Leach also oversees corporate development and strategy, per the press release

The filing

CompanyDexcom (DXCM)
Form8-K, current report
Filed with the SECMay 13, 2025, 8:31 AM ET
Accession number0001093557-25-000159

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 13, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.